Iatrogenic hookworm therapy shows promise for treating disorders that result from 27 a dysregulated immune system, including inflammatory bowel disease (IBD). Here we use a 28 metabolomics approach to characterize the non-protein small molecule complement of 29 hookworms. Gas chromatography-mass spectrometry and liquid chromatography-mass 30 spectrometry analyses of somatic tissue extracts revealed the presence of 52 polar metabolites 31 and 22 non-polar components including short chain fatty acids (SCFA). Several of these small 32 metabolites, notably the SCFA, have been shown to have anti-inflammatory properties in various 33 diseases, including IBD. Using a murine model of colitis and human peripheral blood 34 mononuclear cells, we demonstrate that somatic tissue extracts of the hookworm Ancylostoma 35 caninum contain small molecules with anti-inflammatory activities. Of the five extracts tested, 36 two of them significantly protected mice against T cell-mediated immunopathology and weight 37 loss in a chemically-induced colitis model. Moreover, one of the anti-colitic extracts suppressed 38 ex vivo production of inflammatory cytokines from primary human leukocytes. While the origin 39 of the SCFA (parasite or host microbiota-derived) present in the hookworm somatic tissue 40 extracts cannot be ascertained from this study, it is possible that A. caninum may be actively 41 promoting an anti-inflammatory host microbiome by facilitating immune crosstalk through SCFA 42 production. 43 44 Short chain fatty acids; GC-MS; Metabolome 46 47 48 49 50 3 51 52
inflammatory properties on human PBMC stimulated ex vivo with lipopolysaccharide (LPS) to 167 promote cytokine production by myeloid cells or PMA/ionomycin to promote cytokine 168 production by T cells. T cell cytokine production was moderately reduced by SE-HDA at 20 169 g/ml including a 14% reduction in IL-2 (P < 0.001), a 34% reduction in IL-6 (P < 0.05), a 59% 170 reduction in monocyte chemoattactant protein-1 (MCP-1) (P < 0.001) and a 33% reduction in 171 TNF- (P < 0.05) (data not shown) compared to stimulated cells that were not co-cultured with 172 hookworm extracts. We observed a very potent effect of SE-HDA on myeloid cells. LPS-induced 173 cytokines were reduced in the presence of SE-HDA (at 20 g/ml) including an 88% reduction in 174 IL-1 (P < 0.0001), a 37% reduction in IL-6 (P < 0.01), a 58% reduction in TNF- (P < 0.01) and 175 an 84% reduction in MCP-1 (P < 0.0001) ( Fig. 5) . 176 177 <<<Insert Figure 5>>> compounds were identified by comparing their ion patterns with the ion spectra of the known 196 compounds indexed in the NIST database (28). Through GC-MS analyses, we identified a total of 9 32 metabolites from these two bioactive somatic tissue extracts (Table S1 ). Each extract 198 contained 20 metabolites, with 12 of them found exclusively in each extract. Both extracts 199 contained eight medium to long chain free saturated and unsaturated fatty acids (C 11 to C 26 ). 200
Palmitic acid, methyl palmitate, stearic acid and methyl stearate were abundant in both extracts. 201
The most common mono/poly-unsaturated fatty acids present in both crude extracts were oleic 202 acid, linoleic acid, γ-linolenic acid and palmitoleic acid. Six of these fatty acids including stearic 203 acid (C18:0) (29), palmitic acid (C16:0) (30), methyl palmitate (31), γ-linolenic acid (32), 204 palmitoleic acid (C16:1n-7) (33) and oleic acid (C18:1) (29, 34) have been reported to exhibit 205 anti-inflammatory properties. 206
Using LC-MS, we identified eight SCFA, with isovalarate as the major component present 207 in both the SE-MeOH and SE-HDA somatic extracts. Acetate, propionate, butyrate, 2-208 methylbutyrate, isovalerate, caproate and heptanoic acid were present in both protective 209 fractions/extracts (Table S2) . Isobutyrate was present only in the SE-MeOH extract. Acetate, 210
propionate and butyrate (obtained from other synthetic sources) were previously reported to have 211 anti-inflammatory activities (35). 212
Global metabolomes of derivatized whole worm somatic tissue extract of hookworms. 213
Metabolomics analyses of two protective extracts (SE-HDA and SE-MeOH) showed only the 214 representative metabolomes of underivatized samples of hookworm extracts. To gain a global 215 insight of small metabolites present in A. caninum, we conducted a targeted GC-MS and LC-MS 216 metabolomics analyses of the methoximated, trimethylsilyl derivatized whole worm extract. 217
Whole worm extracts were divided into polar and non-polar fractions. From the polar fraction, 218
using GC-MS we identified 47 polar small metabolites (Table S3) From the non-polar fraction, using GC-MS we identified 22 fatty acids (Table S4 ) 228 comprising 17 saturated fatty acids (including stearic acid, palmitic acid, arachidic acid, margaric 229 acid and myristic acid) and five unsaturated fatty acids (including elaidic acid, oleic acid, erucic 230 acid, petroselinic acid, and nervonic acid). Literature review and content analyses revealed that at 231 least seven of these fatty acids including stearic acid (C18:0) (29), palmitic acid (C16:0) (30), 232 methyl palmitate (31), lauric acid (C12:0) (47), capric acid (C10:0) (47), γ-linolenic acid (32) and 233 caprylic acid (C8:0) (48) were previously reported to have anti-inflammatory activities. 234
Using LC-MS analysis, we identified five SCFA from whole worm somatic tissue extracts, 235
including isobutyrate, propionate, 2-methylvalerate, acetate and butyrate (Table S2 ). Of these 236 SCFA, acetate (C2:0), propionate and butyrate (C4:0) have been reported to be effective in 237 preventing inflammation associated with IBD (35). 238
239

DISCUSSION 240
Parasitic helminths, such as hookworms, have evolved to establish chronic infections in the 241 human gut while inducing minimal pathology when present in low numbers (17). Hookworms 242 regulate the immune system of the host for their benefit and subsequently promote a state of 243 immune tolerance. This regulated environment not only promotes longevity for the parasites but 244 also reduces the likelihood of the host developing diseases that result from a dysregulated 245 immune system (49). A significant number of experimental and clinical studies support the 246 immunoregulatory proficiency of parasitic helminths against distinct immunopathologies, 247
including allergies, IBD and other autoimmune diseases (9, 16, 50-53). While iatrogenic infection 248
with hookworms and other helminths shows promise for treating numerous inflammatory 249 diseases in humans, the therapy presents many challenges including patient apprehension, safety 250 concerns and regulatory hurdles (17, 54). We and others showed that A. caninum ES proteins 251 (>10 kDa) have potent immunomodulatory properties and can protect mice against pathology in 252 different inducible models of colitis (17, 19, 20, 55, 56) propionic, isobutyric and branched chain C 5 acids were detected (62). More recently, saturated 313 fatty acids were reported from the ova of A. caninum (65), but the authors did not report the 314 presence of SCFA. 315
The nature and origin of these excreted SCFA of A. caninum were demonstrated through 316 carbon (D-glucose-14 C) isotope/radiocarbon labeling, and indicated the presence of a glucose 317 metabolism intermediate between that observed in aerobes and that characteristic of helminth 318 anaerobes (62). The importance of SCFA as intermediates in the energy metabolism of intestinal 319 parasites in a succinate decarboxylase-dependent manner, as well as uncoupled mitochondrial 320 respiration, has been reported (66). A recent review (67) suggested that formation and excretion 321 of acetate as a metabolic end product of energy metabolism occurs in many protist (Giardia 322 14 lamblia, Entamoeba histolytica, Trichomonas vaginalis, Trypanosoma and Leishmania spp.) and 323 helminth (Fasciola hepatica, Haemonchus contortus and Ascaris suum) parasites from acetyl-324
CoA by two different reactions, both involving substrate level phosphorylation that is catalyzed 325 by either a cytosolic acetyl-CoA synthetase or an organellar acetate:succinate CoA-transferase. 326
However, these enzymes involved in SCFA biosynthesis were poorly represented when we 327 mapped them against the known metabolic pathways (KEGG) of 81 worm genomes including the 328 human hookworm, Necator americanus, and the model free-living nematode, C. elegans. None of 329 the hookworm species represented in genome databases have any annotation associated with 330 SCFA synthesis other than two enzymes involved in propanoate synthesis. It is known that 331 parasitic helminths modulate intestinal inflammation via alteration of the composition of the gut 332 microbiota. This mechanism has been demonstrated both in rodent models (68) and human 333 studies where iatrogenic hookworm infection resulted in increased bacterial species richness and 334 elevated production of SCFA (11, 69). It is apparent that the gut microbiome is a complex 335 ecosystem with microbial syntrophy at the intestinal mucosal interface (70), and that SCFA such 336 as acetate, butyrate and propionate are produced and utilized by bacteria, and benefit host 337 epithelial cells by producing molecules like vitamin B 12 (71). SCFA are key metabolites and 338 energy sources for commensal bacteria at the gut interface. Therefore, while it is possible that A. 339 caninum synthesizes SCFA de novo, further studies will be needed to define the contribution of 340 the commensal microbiome to SCFA synthesis in hookworms. 341
Analyses of the available literature on the biological activities of all the small molecules 342 identified from the somatic tissue extracts of A. caninum showed that 11 polar metabolites (36-343 46), nine medium-long chain fatty acids (29-34, 47, 48), and three SCFA (35) have been 344 previously isolated from different sources and have been found to exhibit anti-inflammatory 345 activities. Of 23 anti-inflammatory small metabolites, only three compounds including one polar 346 metabolite (glycine) and three SCFA (acetate, propionate and butyrate) were studied in vivo 347 against chemically-and stress-induced ulcers in the gastric mucosa (36). Fatty acids, especially 348 SCFA, have roles in host defense against potential opportunistic or pathogenic microorganisms, 349
and establish an immunoregulatory environment that protects against inflammation in both the mice per cage), and allowed to settle into the study facility for 4-5 days prior to the start of the 421 experiment. Animals were housed in a temperature (26°C) and humidity-controlled (40-70%) 422 environment, exposed to a 12-hour day/night cycle, and provided with irradiated mouse chow 423 supplied by Specialty Feeds (Glen Forrest, Western Australia) and autoclaved tap water ad 424
libitum. 425
Experimental design and induction of TNBS colitis. We followed the modified 426 experimental design and TNBS induction protocols described by us earlier (26). Mice were 427 divided into three different groups as "Naïve", "TNBS only" and "TNBS + Sample treatment". were scored from 0-2, 0 being normal and 2 being diseased. A score of "0" was given when the 444 mice gained weight, "1" when weight remained the same and "2" upon losing weight. Mice with 445 no piloerection scored "0," mild piloerection over the neck as "1" and severe piloerection all over 446 the body as "2". The mobility of a mouse was scored as "0" for normal, "1" for movement only 447 after stimulation, and "2" for hunched posture with no movement around the cage, even after 448 stimulation. For fecal consistency, normal feces were scored "0", mild diarrhea was scored "1" 449 and severe diarrhea with blood or no feces was scored "2". After 10 minutes of isolation, the 450 fecal pellets were counted (higher number of pellets indicated normal or mice recovering from 451 chemical colitis). Evaluating colon histological structure. The distal colon tissue sections (1 cm) that 462 were harvested from mice were placed in 4% paraformaldehyde (1 ml) to fix tissue overnight at 463 4°C and then transferred to 70% ethanol for storage. Tissue was embedded in paraffin and 464 sectioned longitudinally for histology at 4 μm thickness. Sections were stained with hematoxylin 465 and eosin (H/E), observed for histological changes by light microscopy and histological 466 photomicrographs (200) were captured. Each histological photomicrograph was blinded and 467 then scored for changes in overall colon morphology and epithelial integrity. The cross-sections 468 of the colon tissues were scored for inflammation, edema, hyperplasia, ulceration and number of 469 goblets cells using a scoring matrix (76). An AxioCam Imager -M1 (MRC ZEISS) was used for 470 20 scoring the colon histology cross-sections. 471
ELISAs and cytokine measurement of colon tissues. Colon pieces (1 cm) were 472 collected and placed in sterile 24 well tissue culture plates with 500 μl of complete medium 473 (RPMI containing 10% fetal bovine serum, 1% penicillin/streptomycin, 0.1% β-mercaptoethanol, 474 1% HEPES buffer. Tissues were cultured for 24 h at 37°C (supplied with 5% CO 2 ) after which 475 supernatants were collected and stored at −80°C until further analysis. Colon culture supernatants 476 were thawed and levels of cytokines were quantified using a sandwich enzyme-linked 477 immunosorbent assay (ELISA) (Ready-SET-Go!, eBiosciences) following the manufacturer's 478 instructions. OD 490 values were measured using a POLARstar Omega plate reader (BMG 479 LABTECH) and were expressed as picogram (pg) of tissue weight per mL. 480
Human PBMC collection and culture conditions. The human blood used for this study 481 was obtained from healthy volunteer donors. Written informed consent was obtained from each 482 donor at the time of blood draw. Ethical approval for this research was obtained from the James 483
Cook University Human Ethics Committee. PBMC were isolated from whole blood by density plates were incubated overnight at 37°C and 6.5% CO 2 . After incubation, the samples were 492 centrifuged at 1,500 g for 5 minutes and the culture supernatants were collected for cytokine 493 analysis. 494 21 BD™ Cytometric Bead Array. IL-1β, IL-6, IL-12, TNF- and MCP-1 from PBMC 495 culture supernatant were quantified using a cytometric bead array (CBA) (BD™ Biosciences). 496
The CBA assays were performed according to the manufacturer's instruction and run using a five 497 laser Special Order LSRFortessa™ with HTS (BD Biosciences). Cytokine concentrations (pg/ml) 498
were calculated based on the sample MFI compared to the cytokine standard curves. BD™ FCAP 499
Array software version 3.0 was used for data analysis. Graphs and statistical analysis were 500 produced using GraphPad Prism version 7.02 (GraphPad Software Inc). 501
Cryomill somatic tissue extraction of adult worms for GC-MS metabolomics 502
analysis. Somatic tissue extract of adult A. caninum (10-20 mg) was snap-frozen in liquid 503 nitrogen to arrest metabolic changes, placed in cryomill tubes, then suspended in 600 µl 504 extraction solution (methanol:water 3:1 (v/v) containing internal standards 13 C, 15 N-valine and 505 13 C-sorbitol). The sample was extracted using a Precellys 24 Cryolys unit (Bertin Technologies) 506 at 6800 rpm, 3  30 sec pulses, 45 second interval between pulses, temperature < 5°C (pre-507 chilled with liquid nitrogen). The homogenate was transferred to a fresh microfuge tube on ice 508 and chilled chloroform (150 µl) was added. The solution (chloroform:methanol:water 1:3:1 (v/v) 509 monophasic mixture) was vortexed vigorously chilled on ice for 10 minutes with regular mixing 510 and then centrifuged for 5 minutes at 0°C. The supernatant was transferred to a fresh 1.5 ml 511 microfuge tube on ice and milli-Q water (300 µL) was added to each tube to obtain a biphasic 512 partition of the solution (chloroform:methanol:water 1:3:3 (v/v)). The sample was vortexed 513 vigorously and then centrifuged at 0°C for a further 5 minutes. 514
For total fatty acid analyses, the bottom chloroform extract (45 µl) was transferred to 515 fresh tubes and 0.2M m-trifluromethylphenyl trimethyl ammonium hydroxide (methprep) (5 µl) 516 was added. Samples (5 replicates) were mixed using a thermomixer at 750 rpm for 30 minutes at 517 37°C. The samples were injected (2 µl) into an Agilent 7000 triple quad GC-MS (1:10 split 518 injection, BPX70 60 m x 0.25 mm x 0.25 µm column) and the raw data were obtained and 519 processed. 520
Derivatization method for targeted metabolite analysis using GC-MS. The upper 521 aqueous phase (methanol:water, ~900 µl) was transferred to a fresh tube, then aliquoted (50 µl) 522 0.25 mm × 0.25 µm). Conditions for the oven were set at 35°C, held for 2 minutes, then ramped 531 at 25°C/minute to 325°C and held for 5 minutes. Helium was used as the carrier gas at a flow rate 532 of 1 ml/minute, with compounds being detected across the m/z range of 50-600 atomic mass unit 533 (amu). 534
GC-MS analyses of SE-HDA and SE-MeOH extracts using underivatized protocols. 535
We performed GC-MS analysis on the two bioactive extracts using methods described by us 536 previously (78). The dried crude fractions were re-suspended in chloroform-methanol solvent 537 (90%:10%) and were directly injected into a Shimadzu GC-2010 Plus system to analyse their 538 chemical constituents. The GC system used helium as a carrier gas (1.22 mL/min, pressure 67.7 539 kPa at 40°C in a constant total flow mode) and the separation was achieved using a DB-5 ms 540 column (l30 m length  0.25 mm, i.d., 0.25 μm, Phenomenex). Injector (injectionsplitless 541 mode) and detector temperatures were set at 225°C and 300°C, respectively. The starting oven 542 temperature was programmed at 45°C with an increasing temperature of 3°C/minute until it 543 reached 100°C (hold time = 4 minutes) and final temperature of 240°C (hold time = 50 minutes). 544 Similarly, the same equipment was programed for the MS system (condition and column same as were used as standards (5 M and 50 M concentrations). These SCFA were mapped against the 561 existing 81 worm genome KEGG pathways to understand their biosynthetic nature. 562
Statistical and data analyses. The data from groups of mice from 2 independent 563 experiments (N =10) were combined and the statistical analyses were performed using GraphPad 564 Prism (version 7.0) as described earlier (76). Comparisons were made between the sample 565 treatment + TNBS groups and the TNBS only group; P values of < 0.05 were considered 566 significant. When determining the differences between more than two groups with equal numbers 567 of mice/samples, 2-way ANOVA was used. When two groups were compared a Mann-Whitney 568 (unpaired, non-parametric) t-test was applied. All results reported denote mean ± standard error 569 of the mean (SEM). The metabolomics data was analyzed in a targeted approach using Agilent's 570 Mass Hunter Quantitative Analysis software (v.7). Target ion peak areas for polar and non-polar 571 metabolites were extracted using the in-house Metabolomics Australia metabolite library and 572 were integrated and output as a data matrix for further analysis (section 3.5). 
